IP Verse

Enhancing Anti Cancer Activity Of Immunomodulatory Fc Fusion Proteins - EP2925350

PATENT ANALYSIS

Patent Details

Grant Date
Jan 30, 2019
Company
BRISTOL-MYERS SQUIBB COMPANY
Oppositions

PLOUGMANN VINGTOFT A/S

More patents of Bristol-Myers Squibb Company

EP3631454

EP3559230

EP3227333

Want to monitor this patent?

Feel free to send us a message here and we will get back to you